Upstream Bio, Inc.
UPB
$5.85
-$0.35-5.57%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.98% | 44.69% | 20.42% | 26.82% | 22.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.98% | 44.69% | 20.42% | 26.82% | 22.60% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 15.98% | 44.69% | 20.42% | 26.82% | 22.60% |
| SG&A Expenses | 16.73% | 38.64% | 53.83% | 63.44% | 74.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.30% | 80.59% | 103.68% | 110.80% | 112.50% |
| Operating Income | -39.82% | -81.46% | -106.21% | -113.62% | -116.05% |
| Income Before Tax | -49.80% | -97.98% | -128.39% | -128.90% | -157.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.80% | -97.98% | -128.39% | -128.90% | -157.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.80% | -97.98% | -128.39% | -128.90% | -157.91% |
| EBIT | -39.82% | -81.46% | -106.21% | -113.62% | -116.05% |
| EBITDA | -39.83% | -81.49% | -106.21% | -113.52% | -116.01% |
| EPS Basic | 60.49% | 72.11% | 81.73% | 85.99% | 53.36% |
| Normalized Basic EPS | 58.82% | 73.96% | 81.34% | 86.82% | 48.23% |
| EPS Diluted | 60.49% | 72.11% | 81.73% | 85.99% | 53.36% |
| Normalized Diluted EPS | 58.82% | 73.96% | 81.34% | 86.82% | 48.23% |
| Average Basic Shares Outstanding | 38.95% | 105.15% | 293.59% | 1,623.98% | 1,207.07% |
| Average Diluted Shares Outstanding | 38.95% | 105.15% | 293.59% | 1,623.98% | 1,207.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |